Staphylococcus epidermidis RP12 is an aerobe, Gram-positive, coccus-shaped bacterium that was isolated from Human blood.
Gram-positive coccus-shaped aerobe 16S sequence Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus epidermidis |
| Full scientific name Staphylococcus epidermidis (Winslow and Winslow 1908) Evans 1916 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Composition | Medium link | |
|---|---|---|---|---|---|
| 35960 | MEDIUM 3 - Columbia agar | Columbia agar (39.000 g);distilled water (1000.000 ml) | |||
| 35960 | CIP Medium 72 | Medium recipe at CIP | |||
| 35960 | CIP Medium 3 | Medium recipe at CIP |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68371 | 18305 ChEBI | arbutin | - | builds acid from | from API 50CH acid |
| 68375 | 29016 ChEBI | arginine | + | hydrolysis | from API ID32STA |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68371 | 17057 ChEBI | cellobiose | - | builds acid from | from API 50CH acid |
| 68371 | 17108 ChEBI | D-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68371 | 15824 ChEBI | D-fructose | + | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 12936 ChEBI | D-galactose | + | builds acid from | from API 50CH acid |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68371 | 17634 ChEBI | D-glucose | + | builds acid from | from API 50CH acid |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68375 | 16899 ChEBI | D-mannitol | - | fermentation | from API ID32STA |
| 68371 | 16899 ChEBI | D-mannitol | - | builds acid from | from API 50CH acid |
| 68375 | 16024 ChEBI | D-mannose | - | fermentation | from API ID32STA |
| 68371 | 16024 ChEBI | D-mannose | - | builds acid from | from API 50CH acid |
| 68375 | 16988 ChEBI | D-ribose | - | fermentation | from API ID32STA |
| 68371 | 16988 ChEBI | D-ribose | + | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | - | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68371 | 65327 ChEBI | D-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 68371 | 4853 ChEBI | esculin | - | builds acid from | from API 50CH acid |
| 68371 | 16813 ChEBI | galactitol | - | builds acid from | from API 50CH acid |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 68371 | 24265 ChEBI | gluconate | - | builds acid from | from API 50CH acid |
| 68371 | 17754 ChEBI | glycerol | + | builds acid from | from API 50CH acid |
| 68371 | 28087 ChEBI | glycogen | - | builds acid from | from API 50CH acid |
| 35960 | 606565 ChEBI | hippurate | - | hydrolysis | |
| 68371 | 15443 ChEBI | inulin | - | builds acid from | from API 50CH acid |
| 68371 | 30849 ChEBI | L-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 18287 ChEBI | L-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 50CH acid |
| 68371 | 17266 ChEBI | L-sorbose | - | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 68375 | 17716 ChEBI | lactose | + | fermentation | from API ID32STA |
| 68371 | 17716 ChEBI | lactose | + | builds acid from | from API 50CH acid |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68371 | 17306 ChEBI | maltose | + | builds acid from | from API 50CH acid |
| 68371 | 6731 ChEBI | melezitose | + | builds acid from | from API 50CH acid |
| 68371 | 28053 ChEBI | melibiose | - | builds acid from | from API 50CH acid |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 17268 ChEBI | myo-inositol | - | builds acid from | from API 50CH acid |
| 68375 | 59640 ChEBI | N-acetylglucosamine | - | fermentation | from API ID32STA |
| 68371 | 59640 ChEBI | N-acetylglucosamine | + | builds acid from | from API 50CH acid |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 35960 | 17632 ChEBI | nitrate | + | reduction | |
| 35960 | 16301 ChEBI | nitrite | - | reduction | |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68371 | 0 ChEBI | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid |
| 68371 | 0 ChEBI | Potassium 5-ketogluconate | - | builds acid from | from API 50CH acid |
| 68375 | 16634 ChEBI | raffinose | - | fermentation | from API ID32STA |
| 68371 | 16634 ChEBI | raffinose | + | builds acid from | from API 50CH acid |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 68371 | 17814 ChEBI | salicin | - | builds acid from | from API 50CH acid |
| 68371 | 28017 ChEBI | starch | - | builds acid from | from API 50CH acid |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68371 | 17992 ChEBI | sucrose | + | builds acid from | from API 50CH acid |
| 68375 | 27082 ChEBI | trehalose | - | fermentation | from API ID32STA |
| 68371 | 27082 ChEBI | trehalose | - | builds acid from | from API 50CH acid |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| 68371 | 32528 ChEBI | turanose | + | builds acid from | from API 50CH acid |
| 68375 | 16199 ChEBI | urea | + | hydrolysis | from API ID32STA |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | ChEBI | Group ID | Metabolite | Is sensitive | Sensitivity conc. | |
|---|---|---|---|---|---|---|
| 68375 | 28368 | 0 | novobiocin | 1.8 µg | from API ID32STA |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 35960 | alcohol dehydrogenase | + | 1.1.1.1 | |
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | + | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 35960 | amylase | - | ||
| 68375 | arginine dihydrolase | + | 3.5.3.6 | from API ID32STA |
| 35960 | beta-galactosidase | + | 3.2.1.23 | |
| 68375 | beta-galactosidase | - | 3.2.1.23 | from API ID32STA |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 35960 | caseinase | + | 3.4.21.50 | |
| 35960 | catalase | + | 1.11.1.6 | |
| 35960 | coagulase | - | ||
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 35960 | DNase | - | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 35960 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 35960 | gelatinase | +/- | ||
| 68375 | L-arginine arylamidase | - | from API ID32STA | |
| 35960 | lecithinase | - | ||
| 68382 | leucine arylamidase | - | 3.4.11.1 | from API zym |
| 35960 | lipase | - | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 35960 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | - | from API zym | |
| 35960 | ornithine decarboxylase | - | 4.1.1.17 | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| 35960 | oxidase | - | ||
| 35960 | phenylalanine ammonia-lyase | - | 4.3.1.24 | |
| 35960 | protease | + | ||
| 68375 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API ID32STA |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 35960 | tween esterase | - | ||
| 35960 | urease | + | 3.5.1.5 | |
| 68375 | urease | + | 3.5.1.5 | from API ID32STA |
| 68382 | valine arylamidase | - | from API zym |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35960 | not determinedn.d. | + | - | - | - | + | - | - | - | - | + | + | + | - | - | - | - | - | - | - | - | - | + | - | - | - | - | - | + | + | - | + | - | - | + | + | - | - | - | - | + | - | - | - | - | - | - | - | - | - |
| @ref | Biosafety level | Biosafety level comment | |
|---|---|---|---|
| 35960 | 1 | Risk group (French classification) |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Enzymology | In Vitro and In Silico Approaches for the Evaluation of Antimicrobial Activity, Time-Kill Kinetics, and Anti-Biofilm Potential of Thymoquinone (2-Methyl-5-propan-2-ylcyclohexa-2,5-diene-1,4-dione) against Selected Human Pathogens. | Qureshi KA, Imtiaz M, Parvez A, Rai PK, Jaremko M, Emwas AH, Bholay AD, Fatmi MQ. | Antibiotics (Basel) | 10.3390/antibiotics11010079 | 2022 | |
| Natural Compounds with Antimicrobial Properties in Cosmetics. | Rybczynska-Tkaczyk K, Grenda A, Jakubczyk A, Kiersnowska K, Bik-Malodzinska M. | Pathogens | 10.3390/pathogens12020320 | 2023 | ||
| Enzymology | Kombucha - An ancient fermented beverage with desired bioactivities: A narrowed review. | Abaci N, Senol Deniz FS, Orhan IE. | Food Chem X | 10.1016/j.fochx.2022.100302 | 2022 | |
| LC-ESI/MS-Phytochemical Profiling with Antioxidant, Antibacterial, Antifungal, Antiviral and In Silico Pharmacological Properties of Algerian Asphodelus tenuifolius (Cav.) Organic Extracts. | Khalfaoui A, Noumi E, Noumi E, Belaabed S, Aouadi K, Lamjed B, Adnan M, Defant A, Kadri A, Snoussi M, Khan MA, Mancini I. | Antioxidants (Basel) | 10.3390/antiox10040628 | 2021 | ||
| Plant Growth Modulates Metabolites and Biological Activities in Retama raetam (Forssk.) Webb. | Saada M, Falleh H, Catarino MD, Cardoso SM, Ksouri R. | Molecules | 10.3390/molecules23092177 | 2018 | ||
| A Review on the Cosmeceutical and External Applications of Nigella sativa. | Eid AM, Elmarzugi NA, Abu Ayyash LM, Sawafta MN, Daana HI. | J Trop Med | 10.1155/2017/7092514 | 2017 | ||
| A systematic review of antibacterial activity of polyphenolic extract from date palm (Phoenix dactylifera L.) kernel. | Bhaskaracharya RK, Bhaskaracharya A, Stathopoulos C. | Front Pharmacol | 10.3389/fphar.2022.1043548 | 2022 | ||
| Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. | Forouzanfar F, Bazzaz BS, Hosseinzadeh H. | Iran J Basic Med Sci | 2014 | |||
| Pathogenicity | Antibacterial and resistance-modifying activities of thymoquinone against oral pathogens. | Kouidhi B, Zmantar T, Jrah H, Souiden Y, Chaieb K, Mahdouani K, Bakhrouf A. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-10-29 | 2011 | |
| Fermented Seeds ("Zgougou") from Aleppo Pine as a Novel Source of Potentially Probiotic Lactic Acid Bacteria. | Missaoui J, Saidane D, Mzoughi R, Minervini F. | Microorganisms | 10.3390/microorganisms7120709 | 2019 | ||
| Chemical Constitution and Antimicrobial Activity of Kombucha Fermented Beverage. | Al-Mohammadi AR, Ismaiel AA, Ibrahim RA, Moustafa AH, Abou Zeid A, Enan G. | Molecules | 10.3390/molecules26165026 | 2021 | ||
| Use of Autochthonous Lactobacilli to Increase the Safety of Zgougou. | Minervini F, Missaoui J, Celano G, Calasso M, Achour L, Saidane D, Gobbetti M, De Angelis M. | Microorganisms | 10.3390/microorganisms8010029 | 2019 | ||
| Evaluation of the cytotoxic effect and antibacterial, antifungal, and antiviral activities of Hypericum triquetrifolium Turra essential oils from Tunisia. | Rouis Z, Abid N, Koudja S, Yangui T, Elaissi A, Cioni PL, Flamini G, Aouni M. | BMC Complement Altern Med | 10.1186/1472-6882-13-24 | 2013 | ||
| A review on therapeutic potential of Nigella sativa: A miracle herb. | Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, Damanhouri ZA, Anwar F. | Asian Pac J Trop Biomed | 10.1016/s2221-1691(13)60075-1 | 2013 | ||
| Biofilm formation and role of other pathogenic factors in the virulence of Staphylococcus epidermidis clinical isolates. | Fernandez-Calderon MC, Fernandez-Babiano I, Navarro-Perez ML, Pazos-Pacheco C, Calvo-Cano A. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1630341 | 2025 | ||
| Anti-Biofilm Perspectives of Propolis against Staphylococcus epidermidis Infections. | Vadillo-Rodriguez V, Fernandez-Babiano I, Perez-Giraldo C, Fernandez-Calderon MC. | Biomolecules | 10.3390/biom14070779 | 2024 | ||
| Experimental study on factors influencing low identification rates and spectral quality of Streptococcus pneumoniae using the Sepsityper kit. | Choi H, Kang M, Ko Y-K, Yu H-J, Kim TY, Huh HJ, Lee NY, Lee H-S. | Microbiol Spectr | 10.1128/spectrum.01084-25 | 2025 | ||
| Phylogeny | Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections. | Santos INM, Alberto-Lei F, Santos FF, Balera MFC, Kurihara MN, Cunha CC, Seriacopi LS, Durigon TS, Reis FB, Eisen AKA, Caleiro GS, de Araujo J, Durigon EL, Klautau GB, Salles MJ. | Sci Rep | 10.1038/s41598-025-09061-4 | 2025 | |
| Antibiofilm Effect of Silver Nanoparticles in Changing the Biofilm-Related Gene Expression of Staphylococcus epidermidis. | Swolana D, Kepa M, Kruszniewska-Rajs C, Wojtyczka RD. | Int J Mol Sci | 10.3390/ijms23169257 | 2022 | ||
| Genetics | Genomic and phenotypic characterization of staphylococci isolated from the skin of non-human primates. | Wildsmith C, Barratt S, Kerridge F, Thomas J, Negus D. | Microbiology (Reading) | 10.1099/mic.0.001546 | 2025 | |
| Berberine and its nanoformulations and extracts: potential strategies and future perspectives against multi-drug resistant bacterial infections. | Yang X, Wang Y, Li L, Tang D, Yan Z, Li M, Jiang J, Bi D. | Front Microbiol | 10.3389/fmicb.2025.1643409 | 2025 | ||
| The Antibacterial Effect of Silver Nanoparticles on Staphylococcus epidermidis Strains with Different Biofilm-Forming Ability. | Swolana D, Kepa M, Idzik D, Dziedzic A, Kabala-Dzik A, Wasik TJ, Wojtyczka RD. | Nanomaterials (Basel) | 10.3390/nano10051010 | 2020 | ||
| Staphylococcal Biofilm on the Surface of Catheters: Electron Microscopy Evaluation of the Inhibition of Biofilm Growth by RNAIII Inhibiting Peptide. | de Oliveira A, Pinheiro-Hubinger L, Pereira VC, Riboli DFM, Martins KB, Romero LC, Cunha MLRSD. | Antibiotics (Basel) | 10.3390/antibiotics10070879 | 2021 | ||
| Comparison of Coculture Models of Eukaryotic Cells With Pathogenic and/or Commensal Bacteria for Tissue Engineering. | Buchar Klinovska O, Vavrova A, Benson V, Hubalek Kalbacova M. | Biotechnol Appl Biochem | 10.1002/bab.2717 | 2025 | ||
| In Vitro Investigation of the Antimicrobial Properties of Gerês Propolis in Bacteria Isolated from Companion Animals and Safety Profile Characterization Using the Galleria mellonella Model | Rodrigues R, Almeida R, Rodrigues S, Castro J, Oliveira R, Mendes N, Almeida C, Silva S, Araujo D, Almeida-Aguiar C. | Pathogens | 2025 | |||
| The Array of Antibacterial Action of Protocatechuic Acid Ethyl Ester and Erythromycin on Staphylococcal Strains. | Miklasinska-Majdanik M, Kepa M, Kulczak M, Ochwat M, Wasik TJ. | Antibiotics (Basel) | 10.3390/antibiotics11070848 | 2022 | ||
| Species identification by MALDI-TOF MS and gap PCR-RFLP of non-aureus Staphylococcus, Mammaliicoccus, and Streptococcus spp. associated with sheep and goat mastitis. | Rosa NM, Penati M, Fusar-Poli S, Addis MF, Tola S. | Vet Res | 10.1186/s13567-022-01102-4 | 2022 | ||
| Chemical Profile and Antibacterial Activity of a Novel Spanish Propolis with New Polyphenols also Found in Olive Oil and High Amounts of Flavonoids. | Fernandez-Calderon MC, Navarro-Perez ML, Blanco-Roca MT, Gomez-Navia C, Perez-Giraldo C, Vadillo-Rodriguez V. | Molecules | 10.3390/molecules25153318 | 2020 | ||
| Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics. | Rodrigues AS, Batista JGS, Rodrigues MAV, Thipe VC, Minarini LAR, Lopes PS, Lugao AB. | Front Microbiol | 10.3389/fmicb.2024.1440065 | 2024 | ||
| Isolation and Characterization of a Weizmannia coagulans Bacteriophage Youna2 and Its Endolysin PlyYouna2. | Son B, Kim Y, Yu B, Kong M. | J Microbiol Biotechnol | 10.4014/jmb.2303.03021 | 2023 | ||
| Activity of Silver Nanoparticles against Staphylococcus spp. | Swolana D, Wojtyczka RD. | Int J Mol Sci | 10.3390/ijms23084298 | 2022 | ||
| Novel Colorimetric and Light Scatter Methods to Identify and Manage Peritoneal Dialysis-Associated Peritonitis at the Point-of-Care. | Govindji-Bhatt N, Kennedy SM, Barker MG, Kell D, Henderson D, Goddard N, Garcia AY, Milner AS, Willett T, Griffiths R, Foster P, Kilgallon W, Cant R, Knight CG, Lewis D, Corbett R, Akbani H, Woodrow G, Sood B, Iyasere O, Davies S, Qazi J, Vardhan A, Gillis L, Wilkie M, Dobson CB. | Kidney Int Rep | 10.1016/j.ekir.2023.12.021 | 2024 | ||
| Bacterial Response to the Surface Aging of PLA Matrices Loaded with Active Compounds. | Fernandez-Grajera M, Gallardo-Moreno AM, Luque-Agudo V, Gonzalez-Martin ML, Hierro-Oliva M. | Polymers (Basel) | 10.3390/polym14224976 | 2022 | ||
| Pathogenicity | Detection of the agr System and Resistance to Antimicrobials in Biofilm-Producing S. epidermidis. | Cataneli Pereira V, Pinheiro-Hubinger L, de Oliveira A, Moraes Riboli DF, Benini Martins K, Calixto Romero L, Ribeiro de Souza da Cunha ML. | Molecules | 10.3390/molecules25235715 | 2020 | |
| Standardization and Classification of In vitro Biofilm Formation by Clinical Isolates of Staphylococcus aureus. | Singh AK, Prakash P, Achra A, Singh GP, Das A, Singh RK. | J Glob Infect Dis | 10.4103/jgid.jgid_91_16 | 2017 | ||
| Complete Genome Sequence of a Staphylococcus epidermidis Bacteriophage Isolated from the Anterior Nares of Humans. | Aswani VH, Tremblay DM, Moineau S, Shukla SK. | Genome Announc | 10.1128/genomea.00549-14 | 2014 | ||
| Cationic homopolypeptides: A versatile tool to design multifunctional antimicrobial nanocoatings. | Kocgozlu L, Mutschler A, Tallet L, Calligaro C, Knopf-Marques H, Lebaudy E, Mathieu E, Rabineau M, Gribova V, Senger B, Vrana NE, Lavalle P. | Mater Today Bio | 10.1016/j.mtbio.2024.101168 | 2024 | ||
| Enzymology | Staphylococcus epidermidis bacteriophages from the anterior nares of humans. | Aswani V, Tremblay DM, Moineau S, Shukla SK. | Appl Environ Microbiol | 10.1128/aem.05367-11 | 2011 | |
| Pathogenicity | Phenotypic and genotypic characterization of biofilm producing clinical coagulase negative staphylococci from Nepal and their antibiotic susceptibility pattern. | Manandhar S, Singh A, Varma A, Pandey S, Shrivastava N. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-021-00447-6 | 2021 | |
| Statistical analysis of long- and short-range forces involved in bacterial adhesion to substratum surfaces as measured using atomic force microscopy. | Chen Y, Busscher HJ, van der Mei HC, Norde W. | Appl Environ Microbiol | 10.1128/aem.00502-11 | 2011 | ||
| Metabolism | Role of extracellular polymeric substances in polymicrobial biofilm infections of Staphylococcus epidermidis and Candida albicans modelled in the nematode Caenorhabditis elegans. | Holt JE, Houston A, Adams C, Edwards S, Kjellerup BV. | Pathog Dis | 10.1093/femspd/ftx052 | 2017 | |
| In Vitro Antimicrobial Activity of Ethanolic Extract of Polish Propolis against Biofilm Forming Staphylococcus epidermidis Strains. | Wojtyczka RD, Kepa M, Idzik D, Kubina R, Kabala-Dzik A, Dziedzic A, Wasik TJ. | Evid Based Complement Alternat Med | 10.1155/2013/590703 | 2013 | ||
| Identification of simple arylfluorosulfates as potent agents against resistant bacteria. | Zhang J, Zhao X, Cappiello JR, Yang Y, Cheng Y, Liu G, Fang W, Luo Y, Zhang Y, Dong J, Zhang L, Sharpless KB. | Proc Natl Acad Sci U S A | 10.1073/pnas.2103513118 | 2021 | ||
| In vitro interactions between bacteria, osteoblast-like cells and macrophages in the pathogenesis of biomaterial-associated infections. | Subbiahdoss G, Fernandez IC, Domingues JF, Kuijer R, van der Mei HC, Busscher HJ. | PLoS One | 10.1371/journal.pone.0024827 | 2011 | ||
| Metabolism | Staphylococcus epidermidis and Staphylococcus haemolyticus: Molecular Detection of Cytotoxin and Enterotoxin Genes. | Pinheiro L, Brito CI, de Oliveira A, Martins PY, Pereira VC, da Cunha Mde L. | Toxins (Basel) | 10.3390/toxins7093688 | 2015 | |
| Antibacterial Designs for Implantable Medical Devices: Evolutions and Challenges. | Cao H, Qiao S, Qin H, Jandt KD. | J Funct Biomater | 10.3390/jfb13030086 | 2022 | ||
| Genetics | Comparative Genomics Study of Staphylococcus epidermidis Isolates from Orthopedic-Device-Related Infections Correlated with Patient Outcome. | Post V, Harris LG, Morgenstern M, Mageiros L, Hitchings MD, Meric G, Pascoe B, Sheppard SK, Richards RG, Moriarty TF. | J Clin Microbiol | 10.1128/jcm.00881-17 | 2017 | |
| Reduced susceptibility to vancomycin and biofilm formation in methicillin-resistant Staphylococcus epidermidis isolated from blood cultures. | Pinheiro L, Brito CI, Pereira VC, Oliveira Ad, Camargo CH, Cunha Mde L. | Mem Inst Oswaldo Cruz | 10.1590/0074-0276140120 | 2014 | ||
| Enzymology | Biophysical separation of Staphylococcus epidermidis strains based on antibiotic resistance. | Jones PV, Huey S, Davis P, Yanashima R, McLemore R, McLaren A, Hayes MA. | Analyst | 10.1039/c5an00906e | 2015 | |
| Nanomechanical characterization of soft nanomaterial using atomic force microscopy. | Lam CD, Park S. | Mater Today Bio | 10.1016/j.mtbio.2025.101506 | 2025 | ||
| Pathogenicity | Antimicrobial Resistance Profile of Planktonic and Biofilm Cells of Staphylococcus aureus and Coagulase-Negative Staphylococci. | de Oliveira A, Cataneli Pereira V, Pinheiro L, Moraes Riboli DF, Benini Martins K, Ribeiro de Souza da Cunha Mde L. | Int J Mol Sci | 10.3390/ijms17091423 | 2016 | |
| Pathogenicity | Rhynchophorus palmarum (Linnaeus, 1758) (Coleoptera: Curculionidae): Guarani-Kaiowá indigenous knowledge and pharmacological activities. | Vilharva KN, Leite DF, Santos HFD, Antunes KA, Rocha PDSD, Campos JF, Almeida CV, Macedo MLR, Silva DB, Ramalho de Oliveira CF, Dos Santos EL, de Picoli Souza K. | PLoS One | 10.1371/journal.pone.0249919 | 2021 | |
| Bacterial cell surface deformation under external loading. | Chen Y, Norde W, van der Mei HC, Busscher HJ. | mBio | 10.1128/mbio.00378-12 | 2012 | ||
| Antimicrobial Potential of Bee-Derived Products: Insights into Honey, Propolis and Bee Venom | Grinn-Gofron A, Kolodziejczak M, Hrynkiewicz R, Lewandowski F, Bebnowska D, Adamski C, Niedzwiedzka-Rystwej P. | Pathogens | 2025 | |||
| Pathogenicity | Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis. | Dominguez-Herrera J, Docobo-Perez F, Lopez-Rojas R, Pichardo C, Ruiz-Valderas R, Lepe JA, Pachon J. | Antimicrob Agents Chemother | 10.1128/aac.05606-11 | 2012 | |
| Genetics | Characterization and Genomic Analysis of PALS2, a Novel Staphylococcus Jumbo Bacteriophage. | Lee Y, Son B, Cha Y, Ryu S. | Front Microbiol | 10.3389/fmicb.2021.622755 | 2021 | |
| Dendrimers and Polyamino-Phenolic Ligands: Activity of New Molecules Against Legionella pneumophila Biofilms. | Andreozzi E, Barbieri F, Ottaviani MF, Giorgi L, Bruscolini F, Manti A, Battistelli M, Sabatini L, Pianetti A. | Front Microbiol | 10.3389/fmicb.2016.00289 | 2016 | ||
| Pathogenicity | Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampin. | Darouiche RO, Fowler VG, Adal K, Kielhofner M, Mansouri D, Reller LB. | Antimicrob Agents Chemother | 10.1128/aac.46.2.543-545.2002 | 2002 | |
| Are the soft, liquid-like structures detected around bacteria by ambient dynamic atomic force microscopy capsules? | Mendez-Vilas A, Labajos-Broncano L, Perera-Nunez J, Gonzalez-Martin ML. | Appl Environ Microbiol | 10.1128/aem.01262-10 | 2011 | ||
| Enzymology | A novel, nested, multiplex, real-time PCR for detection of bacteria and fungi in blood. | Gosiewski T, Jurkiewicz-Badacz D, Sroka A, Brzychczy-Wloch M, Bulanda M. | BMC Microbiol | 10.1186/1471-2180-14-144 | 2014 | |
| (68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections. | Ahtinen H, Kulkova J, Lindholm L, Eerola E, Hakanen AJ, Moritz N, Soderstrom M, Saanijoki T, Jalkanen S, Roivainen A, Aro HT. | EJNMMI Res | 10.1186/s13550-014-0045-3 | 2014 | ||
| Enzymology | Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue. | Maciejewska B, Zrubek K, Espaillat A, Wisniewska M, Rembacz KP, Cava F, Dubin G, Drulis-Kawa Z. | Sci Rep | 10.1038/s41598-017-14797-9 | 2017 | |
| Pathogenicity | Antimicrobial resistance and virulence characterization of Staphylococcus aureus and coagulase-negative staphylococci from imported beef meat. | Osman K, Alvarez-Ordonez A, Ruiz L, Badr J, ElHofy F, Al-Maary KS, Moussa IMI, Hessain AM, Orabi A, Saad A, Elhadidy M. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-017-0210-4 | 2017 | |
| Biotechnology | Poultry and beef meat as potential seedbeds for antimicrobial resistant enterotoxigenic Bacillus species: a materializing epidemiological and potential severe health hazard. | Osman KM, Kappell AD, Orabi A, Al-Maary KS, Mubarak AS, Dawoud TM, Hemeg HA, Moussa IMI, Hessain AM, Yousef HMY, Hristova KR. | Sci Rep | 10.1038/s41598-018-29932-3 | 2018 | |
| Pathogenicity | Berberine enhances the antibacterial activity of selected antibiotics against coagulase-negative Staphylococcus strains in vitro. | Wojtyczka RD, Dziedzic A, Kepa M, Kubina R, Kabala-Dzik A, Mularz T, Idzik D. | Molecules | 10.3390/molecules19056583 | 2014 | |
| Antimicrobial TiO2 nanocomposite coatings for surfaces, dental and orthopaedic implants. | Kumaravel V, Nair KM, Mathew S, Bartlett J, Kennedy JE, Manning HG, Whelan BJ, Leyland NS, Pillai SC. | Chem Eng J | 10.1016/j.cej.2021.129071 | 2021 | ||
| Phylogeny | Characterization and genomic analysis of two Staphylococcus aureus bacteriophages isolated from poultry/livestock farms. | Yoon H, Yun J, Lim JA, Roh E, Jung KS, Chang Y, Ryu S, Heu S. | J Gen Virol | 10.1099/vir.0.053991-0 | 2013 | |
| Pathogenicity | A C-type lectin from Bothrops jararacussu venom disrupts Staphylococcal biofilms. | Klein RC, Fabres-Klein MH, de Oliveira LL, Feio RN, Malouin F, Ribon Ade O. | PLoS One | 10.1371/journal.pone.0120514 | 2015 | |
| Pathogenic Mechanisms and Host Interactions in Staphylococcus epidermidis Device-Related Infection. | Sabate Bresco M, Harris LG, Thompson K, Stanic B, Morgenstern M, O'Mahony L, Richards RG, Moriarty TF. | Front Microbiol | 10.3389/fmicb.2017.01401 | 2017 | ||
| Metabolism | Deletion of a tumor necrosis superfamily gene in mice leads to impaired healing that mimics chronic wounds in humans. | Petreaca ML, Do D, Dhall S, McLelland D, Serafino A, Lyubovitsky J, Schiller N, Martins-Green MM. | Wound Repair Regen | 10.1111/j.1524-475x.2012.00785.x | 2012 | |
| Nitric oxide-flux dependent bacterial adhesion and viability at fibrinogen-coated surfaces. | Nichols SP, Schoenfisch MH. | Biomater Sci | 10.1039/c3bm60130g | 2013 | ||
| Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. | Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. | Biomaterials | 10.1016/j.biomaterials.2009.01.052 | 2009 | ||
| Enzymology | LysPBC2, a Novel Endolysin Harboring a Bacillus cereus Spore Binding Domain. | Kong M, Na H, Ha NC, Ryu S. | Appl Environ Microbiol | 10.1128/aem.02462-18 | 2019 | |
| Pathogenicity | Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. | Martineau F, Picard FJ, Lansac N, Menard C, Roy PH, Ouellette M, Bergeron MG. | Antimicrob Agents Chemother | 10.1128/aac.44.2.231-238.2000 | 2000 | |
| Enzymology | Rapid identification of bacteria from positive blood cultures by terminal restriction fragment length polymorphism profile analysis of the 16S rRNA gene. | Christensen JE, Stencil JA, Reed KD. | J Clin Microbiol | 10.1128/jcm.41.8.3790-3800.2003 | 2003 | |
| Pathogenicity | Real-time PCR assay for detection of fluoroquinolone resistance associated with grlA mutations in Staphylococcus aureus. | Lapierre P, Huletsky A, Fortin V, Picard FJ, Roy PH, Ouellette M, Bergeron MG. | J Clin Microbiol | 10.1128/jcm.41.7.3246-3251.2003 | 2003 | |
| Metabolism | Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents. | Souli M, Giamarellou H. | Antimicrob Agents Chemother | 10.1128/aac.42.4.939 | 1998 | |
| Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). | Anthony TU, Rubin LG. | Antimicrob Agents Chemother | 10.1128/aac.43.8.2074 | 1999 | ||
| Classification of Clinical Isolates of Klebsiella pneumoniae Based on Their in vitro Biofilm Forming Capabilities and Elucidation of the Biofilm Matrix Chemistry With Special Reference to the Protein Content. | Singh AK, Yadav S, Chauhan BS, Nandy N, Singh R, Neogi K, Roy JK, Srikrishna S, Singh RK, Prakash P. | Front Microbiol | 10.3389/fmicb.2019.00669 | 2019 | ||
| Comparison of methods for the detection of biofilm production in coagulase-negative staphylococci. | Oliveira A, Cunha Mde L. | BMC Res Notes | 10.1186/1756-0500-3-260 | 2010 | ||
| Enzymology | A Shared noncapsular antigen is responsible for false-positive reactions by Staphylococcus epidermidis in commercial agglutination tests for Staphylococcus aureus. | Blake JE, Metcalfe MA. | J Clin Microbiol | 10.1128/jcm.39.2.544-550.2001 | 2001 | |
| Production of extra-cellular slime by Staphylococcus epidermidis during stationary phase of growth: its association with adherence to implantable devices. | Bayston R, Rodgers J. | J Clin Pathol | 10.1136/jcp.43.10.866 | 1990 | ||
| Adherence measured by microtiter assay as a virulence marker for Staphylococcus epidermidis infections. | Deighton MA, Balkau B. | J Clin Microbiol | 10.1128/jcm.28.11.2442-2447.1990 | 1990 | ||
| Identification of an antigenic marker of slime production for Staphylococcus epidermidis. | Christensen GD, Barker LP, Mawhinney TP, Baddour LM, Simpson WA. | Infect Immun | 10.1128/iai.58.9.2906-2911.1990 | 1990 | ||
| Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. | Salzman MB, Isenberg HD, Rubin LG. | J Clin Microbiol | 10.1128/jcm.31.3.475-479.1993 | 1993 | ||
| Pathogenicity | Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. | Mack D, Siemssen N, Laufs R. | Infect Immun | 10.1128/iai.60.5.2048-2057.1992 | 1992 | |
| Pathogenicity | Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product. | Klebanoff SJ, Kazazi F, Van Voorhis WC, Schlechte KG. | Proc Natl Acad Sci U S A | 10.1073/pnas.91.22.10615 | 1994 | |
| Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci. | Kotilainen P, Huovinen P, Eerola E. | J Clin Microbiol | 10.1128/jcm.29.2.315-322.1991 | 1991 | ||
| Association of coagulase-negative staphylococcal slime production and adherence with the development and outcome of adult septicemias. | Kotilainen P. | J Clin Microbiol | 10.1128/jcm.28.12.2779-2785.1990 | 1990 | ||
| Pathogenicity | New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. | Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, Gagnon F, Truchon K, Bastien M, Picard FJ, van Belkum A, Ouellette M, Roy PH, Bergeron MG. | J Clin Microbiol | 10.1128/jcm.42.5.1875-1884.2004 | 2004 | |
| Phenotypic variation of Staphylococcus epidermidis slime production in vitro and in vivo. | Christensen GD, Baddour LM, Simpson WA. | Infect Immun | 10.1128/iai.55.12.2870-2877.1987 | 1987 | ||
| Phylogeny | Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens. | Deighton MA, Franklin JC, Spicer WJ, Balkau B. | Epidemiol Infect | 10.1017/s0950268800029265 | 1988 | |
| Metabolism | Identification and characterization of SirA, an iron-regulated protein from Staphylococcus aureus. | Heinrichs JH, Gatlin LE, Kunsch C, Choi GH, Hanson MS. | J Bacteriol | 10.1128/jb.181.5.1436-1443.1999 | 1999 | |
| Phylogeny | Biotyping coagulase-negative staphylococci. | Hebert GA, Cooksey RC, Clark NC, Hill BC, Jarvis WR, Thornsberry C. | J Clin Microbiol | 10.1128/jcm.26.10.1950-1956.1988 | 1988 | |
| Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. | Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH. | J Clin Microbiol | 10.1128/jcm.22.6.996-1006.1985 | 1985 | ||
| Phylogeny | Characteristics of coagulase-negative staphylococci that help differentiate these species and other members of the family Micrococcaceae. | Hebert GA, Crowder CG, Hancock GA, Jarvis WR, Thornsberry C. | J Clin Microbiol | 10.1128/jcm.26.10.1939-1949.1988 | 1988 | |
| Phylogeny | Study of the impact of cultivation conditions and peg surface modification on the in vitro biofilm formation of Staphylococcus aureus and Staphylococcus epidermidis in a system analogous to the Calgary biofilm device. | Diepoltova A, Konecna K, Jandourek O, Nachtigal P | J Med Microbiol | 10.1099/jmm.0.001371 | 2021 | |
| A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia. | Lankinen P, Lehtimaki K, Hakanen AJ, Roivainen A, Aro HT | EJNMMI Res | 10.1186/2191-219X-2-41 | 2012 | ||
| Pathogenicity | An extracellular Staphylococcus epidermidis polysaccharide: relation to Polysaccharide Intercellular Adhesin and its implication in phagocytosis. | Spiliopoulou AI, Krevvata MI, Kolonitsiou F, Harris LG, Wilkinson TS, Davies AP, Dimitracopoulos GO, Karamanos NK, Mack D, Anastassiou ED | BMC Microbiol | 10.1186/1471-2180-12-76 | 2012 | |
| Pathogenicity | Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. | Chaieb K, Kouidhi B, Jrah H, Mahdouani K, Bakhrouf A | BMC Complement Altern Med | 10.1186/1472-6882-11-29 | 2011 | |
| Pathogenicity | XTT assay for evaluating the effect of alcohols, hydrogen peroxide and benzalkonium chloride on biofilm formation of Staphylococcus epidermidis. | Chaieb K, Zmantar T, Souiden Y, Mahdouani K, Bakhrouf A | Microb Pathog | 10.1016/j.micpath.2010.11.004 | 2010 | |
| Pathogenicity | Mammalian cell growth versus biofilm formation on biomaterial surfaces in an in vitro post-operative contamination model. | Subbiahdoss G, Kuijer R, Busscher HJ, van der Mei HC | Microbiology (Reading) | 10.1099/mic.0.040378-0 | 2010 | |
| Pathogenicity | Bacterial biofilm formation versus mammalian cell growth on titanium-based mono- and bi-functional coating. | Subbiahdoss G, Pidhatika B, Coullerez G, Charnley M, Kuijer R, van der Mei HC, Textor M, Busscher HJ | Eur Cell Mater | 10.22203/ecm.v019a20 | 2010 | |
| Pathogenicity | Microbial biofilm growth versus tissue integration on biomaterials with different wettabilities and a polymer-brush coating. | Subbiahdoss G, Grijpma DW, van der Mei HC, Busscher HJ, Kuijer R | J Biomed Mater Res A | 10.1002/jbm.a.32731 | 2010 | |
| Metabolism | Apoptotic mechanisms within the retina in Staphylococcus epidermidis experimental endophthalmitis. | Pharmakakis NM, Petropoulos IK, Georgakopoulos CD, Vantzou CV, Anastassiou ED, Mavropoulos A, Zolota V | Graefes Arch Clin Exp Ophthalmol | 10.1007/s00417-008-0996-z | 2008 | |
| Metabolism | In-vitro evaluation of the adhesion to polypropylene sutures of non-pigmented, rapidly growing mycobacteria. | Zamora N, Esteban J, Kinnari TJ, Celdran A, Granizo JJ, Zafra C | Clin Microbiol Infect | 10.1111/j.1469-0691.2007.01769.x | 2007 | |
| Pathogenicity | Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. | Peck KR, Kim SW, Jung SI, Kim YS, Oh WS, Lee JY, Jin JH, Kim S, Song JH, Kobayashi H | Chemotherapy | 10.1159/000071143 | 2003 | |
| Pathogenicity | Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms. | Lee CK, Rubin LG, Moldwin RM | Urology | 10.1016/S0090-4295(99)80074-0 | 1995 | |
| Enzymology | Identity of macromolecules present in the extracellular slime layer of Staphylococcus epidermidis. | Karamanos NK, Panagiotopoulou HS, Syrokou A, Frangides C, Hjerpe A, Dimitracopoulos G, Anastassiou ED | Biochimie | 10.1016/0300-9084(96)88127-2 | 1995 | |
| Enzymology | Isolation and characterization of a novel 20-kDa sulfated polysaccharide from the extracellular slime layer of Staphylococcus epidermidis. | Arvaniti A, Karamanos NK, Dimitracopoulos G, Anastassiou ED | Arch Biochem Biophys | 10.1006/abbi.1994.1061 | 1994 | |
| Metabolism | Effect of various microbial preparations on P-388 mouse lymphocytic leukemia. | Antoun MD, Caballero R, Robledo I, Lavergne J | P R Health Sci J | 1992 | ||
| Pathogenicity | Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci. | Gristina AG, Jennings RA, Naylor PT, Myrvik QN, Webb LX | Antimicrob Agents Chemother | 10.1128/AAC.33.6.813 | 1989 | |
| Nanoscopic vibrations of bacteria with different cell-wall properties adhering to surfaces under flow and static conditions. | Song L, Sjollema J, Sharma PK, Kaper HJ, van der Mei HC, Busscher HJ | ACS Nano | 10.1021/nn5030253 | 2014 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #35960 | Collection of Institut Pasteur ; Curators of the CIP; CIP 106510 |
| #56511 | Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 44858 |
| #68371 | Automatically annotated from API 50CH acid . |
| #68375 | Automatically annotated from API ID32STA . |
| #68382 | Automatically annotated from API zym . |
| #124043 | Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive136534.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data